Artivion's Private Capital Credit Facilities
September 29, 2025
Cravath represented Artivion, Inc. in connection with $400 million of credit facilities obtained from Ares Management Credit funds. Artivion is a leader in the manufacturing, processing and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The transaction closed on September 12, 2025.
The Cravath team included partner Joseph D. Zavaglia and associates Kathryn Kennedy Bleday and Jamye Selby.
Related Practices & Industries
People
- Photo
-
-
J.D., 2004, Brooklyn Law SchoolValedictorian, summa cum laude
-
B.B.A., 2001, College of Insurancecum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
February 05, 2024
Artivion, Inc.’s Private Debt Financing
Cravath represented Artivion, Inc. in connection with $350 million of credit facilities obtained from Ares Management Credit funds to comprehensively address its debt maturities. Artivion is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with aortic diseases. The facilities consisted of a $190 million secured term loan facility, a $100 million secured delayed draw term loan facility and a $60 million secured revolving credit facility. The transaction closed on January 18, 2024.
